Eve Review

Eve: a GLP-1 platform built specifically around women

Most GLP-1 telehealth services are gender-neutral by default — the same intake, the same marketing, the same everything whether you're a man or a woman. Eve (which operates as TryEve under the tagline "Empowering Women's Health") is one of the few that openly builds its positioning around women, leaning on "personalized GLP-1 treatments, transparency, and confidence-building outcomes." If you've felt like an afterthought on a generic weight-loss platform, that framing is the reason to give Eve a look. The bigger structural draw, though, is that it carries both compounded and brand-name medications on a single account — a combination that's genuinely rare in this space.

How the pricing actually works

Eve runs two very different price worlds under one roof. Its compounded semaglutide and tirzepatide — including a sublingual oral form — sit at a flat $195 a month. That's a touch above the category median of $170, so it isn't the cheapest compounded option you'll find, but it's in the normal range and the headline number includes the medication, the consult, and shipping rather than tacking those on later.

The brand-name side is a different story. Authentic Ozempic and Mounjaro are listed in the low four figures a month, and Wegovy a few hundred dollars higher. Those are near-retail cash prices with no savings-card or insurance path built in. If you have commercial insurance or qualify for a manufacturer copay card, you will almost certainly pay far less going through a traditional pharmacy than buying brand-name through Eve. The brand option here is really for cash-pay patients who specifically want the FDA-approved product and are willing to pay list-level pricing for it.

One nice friction-reducer: Eve uses a pay-nothing-unless-approved model — you aren't charged until a licensed physician signs off on a plan. There's also a satisfaction guarantee with a money-back promise, and free shipping over a low order threshold. An intro first-month offer has been observed in its signup flow, but Eve doesn't publish a standing teaser rate, so treat any promo as something to confirm at checkout rather than count on.

Medications and how they're dispensed

Eve's catalog is unusually broad for a single provider:

• Compounded semaglutide, injectable
• Compounded oral sublingual semaglutide — a real plus if you're needle-averse
• Compounded tirzepatide, injectable
• Brand-name Ozempic (injection)
• Brand-name Wegovy (injection)
• Brand-name Mounjaro (injection)

Being able to start on affordable compounded therapy and later switch to a brand-name pen — or move between semaglutide and tirzepatide — without changing platforms is the practical payoff of that lineup. The compounded medications are prepared by licensed pharmacies, and to its credit Eve publishes the FDA's standard disclaimer in plain sight: "The FDA does not review or approve any compounded medications for safety or effectiveness." That's the honest framing every compounding provider should show, and many don't.

What sets Eve apart — and where it stays vague

The real differentiators are the women's-health focus, the dual compounded-plus-brand access, and a verifiable trust signal: Eve is LegitScript Certified with a publicly checkable ID (42862417) in its footer, which you can confirm directly on LegitScript's site. For a category full of unverifiable claims, an ID you can look up yourself carries weight.

What keeps our confidence at medium rather than high is what Eve doesn't say. It names a "licensed physician" and "licensed healthcare provider" but no medical director or clinical leadership. The compounding pharmacy partner isn't identified, and there's no statement of whether it's a 503A or 503B facility. The corporate legal entity, governing law, and arbitration venue aren't disclosed, and there's no public list of which states Eve serves — only a note that treatment can continue "if you relocate to a state we currently serve." None of that is disqualifying, but it's information you'd want before committing to an ongoing prescription relationship.

Who should choose Eve

• Women who want a GLP-1 platform that's actually oriented around them
• Cash-pay patients who want the flexibility to move between compounded and brand-name medication on one account
• Anyone who prefers an oral sublingual option over injections
• Shoppers who value a verifiable LegitScript certification and an upfront FDA compounding disclaimer

Who should skip it

• Insured patients eyeing brand-name Ozempic, Wegovy, or Mounjaro — Eve's near-retail cash pricing has no insurance or copay-card path, so compare elsewhere first
• Bargain hunters chasing the rock-bottom compounded price — Eve sits slightly above the category median
• Anyone who needs to confirm their state is served, or who wants a named pharmacy partner and medical director before signing up

Trust and medical oversight

On the positive side: a verifiable LegitScript ID, a visible "consult with a physician" step, the pay-nothing-until-approved gate, a money-back guarantee, and a clearly posted FDA compounding disclaimer are all real, checkable signals — and there are no FDA warning letters on file for Eve in our records. The gaps are about transparency, not red flags: no named pharmacy, no disclosed 503A/503B status, no named clinical leadership, and no public states list. You can read more about how we weigh these factors in our scoring methodology.

Bottom line

Eve is a legitimately differentiated option: women's-health positioning, an oral sublingual choice, and the unusual ability to hold both compounded and brand-name GLP-1s on one account, all backed by a LegitScript ID you can verify yourself. Its compounded $195-a-month pricing is fair if not the cheapest. The brand-name pricing, though, is near retail and makes sense only for cash-pay patients — insured shoppers should look elsewhere for those. Go in with one homework item: confirm your state is served and ask who fills your prescription before you commit.

If you're weighing alternatives, Bodybuilding Health+ ($179/month) and RNK Health ($197/month) are among the closest options we track to Eve.